Latest Prostate Specific Antigen News

PCa Deaths Rare Among Low-Risk Patients on Active Surveillance

PCa Deaths Rare Among Low-Risk Patients on Active Surveillance

Men receiving active surveillance were 24 times more likely to die from causes other than prostate cancer over 15 years.

Early Chemotherapy Offers No Survival Edge in mCRPC

Early Chemotherapy Offers No Survival Edge in mCRPC

Giving docetaxel before abiraterone does not improve progression-free and overall survival compared with the reverse sequence.

MRI-TRUS Biopsy Aids Detection of Locally Recurrent PCa

MRI-TRUS Biopsy Aids Detection of Locally Recurrent PCa

The technique, with cognitive assistance, identified recurrent tumors in 80% of patients.

Prostate Health Index Predicts Post-RARP Prostate Cancer Recurrence

Prostate Health Index Predicts Post-RARP Prostate Cancer Recurrence

A PHI of 82 discriminated between patients with and without biochemical recurrence.

PCPs Screening Less with PSA Per USPSTF Recs

PCPs Screening Less with PSA Per USPSTF Recs

Primary care screening patterns have changed as a result of the USPSTF recommendation.

DRE Has Limited Value for Prostate Cancer Screening

DRE Has Limited Value for Prostate Cancer Screening

Biopsies triggered by an abnormal DRE alone were significantly less likely to detect clinically significant prostate cancer than biopsies triggered by an abnormal PSA alone.

Under and Over Imaging in Castration-Resistant Prostate Cancer

Under and Over Imaging in Castration-Resistant Prostate Cancer

Patients with higher PSA, shorter PSA doubling time more likely to have second bone scan.

PSA Rising While on Abiraterone? Taking It with Food May Help

PSA Rising While on Abiraterone? Taking It with Food May Help

In a small study of mCRPC patients, the median time on therapy increased by nearly 100 days and PSA declined in some subjects.

New Guideline for PCa Survivor Care Endorsed by ASCO

New Guideline for PCa Survivor Care Endorsed by ASCO

Guideline outlines recommended follow-up care for prostate cancer survivors

Underdiagnosis Common Among PCa Active Surveillance Candidates

Underdiagnosis Common Among PCa Active Surveillance Candidates

Just over 41% of patients eligible for active surveillance by European standards were found to have undergraded prostate cancer.

PSA Doubling Time Predicts Salvage Radiation Outcomes

PSA Doubling Time Predicts Salvage Radiation Outcomes

PSA doubling time of 6 months or less and seminal vesicle invasion were significant predictors of biochemical recurrence.

Urology Referrals for Elevated PSA Unchanged

Urology Referrals for Elevated PSA Unchanged

New study examined the effect of a U.S. Preventive Services Task Force 2012 recommendation against routine PSA screening.

Optimal PSA Threshold For Targeted Biopsy Identified

Optimal PSA Threshold For Targeted Biopsy Identified

Diagnostic usefulness of magnetic resonance imaging/ultrasound (MRI/US) fusion targeted prostate biopsy optimized in PSA level of 5.2 ng/mL or higher.

Rising PSA with Testosterone Gel Linked with Specific Factors

Rising PSA with Testosterone Gel Linked with Specific Factors

Greater PSA increases seen in older men and those with lower baseline testosterone.

Early Prostate Cancer Post-Operation PSA Values Useful

Early Prostate Cancer Post-Operation PSA Values Useful

PSA levels at day 30 found to predict biochemical relapse risk in men with positive surgical margins.